Tech Session III: Gene Delivery and Gene Editing II

Chair(s)

• 

  Guarav Sahay, PhD

  Professor
  Oregon State University

Co-Chair(s)

• 

  Yvonne Perrie, PhD (she/her/hers)

  Head of Institute
  University of Strathclyde, Scotland, United Kingdom

Delivery of nucleic acids (mRNA, pDNA, oligonucleotides) with nanoformulations, modulation of protein expression, genome editing, vaccination, overcoming biological limitations (e.g., endosomal escape, cellular targeting, biodistribution).

Presentations:

• 10:04 AM - 10:29 AM EDT

  Enhanced pDNA Delivery Mediated by Backbone-Degradable RAFT Copolymers
  

  Invited Speaker - Exceptional Abstract: Adam J. Gormley, PhD – Rutgers University
• 10:29 AM - 10:54 AM EDT

  DNA-loaded lipid nanoparticles (DNA-LNPs): a platform technology to treat common chronic diseases
  

  Invited Speaker - Exceptional Abstract: Jacob Brenner, MD, PhD – University of Pennsylvania
• 10:54 AM - 11:05 AM EDT

  Lipid Nanoparticle Delivery for CRISPR Gene Editing in Primary Human T-cells
  

  Oral Abstract Speaker: Joy J. Chen, BS – UC Berkeley
• 11:05 AM - 11:16 AM EDT

  Breaking Barriers: Stabilized Lipid Nanoparticles Transform Oral Nucleic Acid Delivery
  

  Oral Abstract Speaker: Kanika Suri, PhD – Takeda Pharmaceuticals, Northeastern University
• 11:16 AM - 11:27 AM EDT

  The lipid nanoparticle shape and morphology affect the efficiency and duration of mRNA transfection
  

  Oral Abstract Speaker: Sara Elsafy, MSc (she/her/hers) – RWTH Aachen University
• 11:27 AM - 11:38 AM EDT

  Optimization of Nanoparticle Delivery of Nucleic Acids to Cells using Poly(glycerol esters)
  

  Oral Abstract Speaker: Brian P. Ginn, PhD (he/him/his) – Secant Group, LLC.
• 11:38 AM - 11:49 AM EDT

  Optimized lipid nanoparticles for CRISPR/Cas9 delivery: advancing gene editing in lung tumor cells
  

  Oral Abstract Speaker: Simone Carneiro, PhD (she/her/hers) – Ludwig-Maximilians-University of Munich